According to the brand's GLP-1 comparison page, Telos Rx offers four distinct formulations, all compounded from licensed US pharmacies: Tirzepatide, a dual GLP-1 and GIP receptor agonist delivered as a weekly subcutaneous injection, positioned by the brand as the strongest appetite-control option
This item is intended solely for in vitro laboratory research use and is not for human or veterinary consumption, nor for use in therapeutic, diagnostic, or clinical applications
Foster GD, Wadden TA, Makris AP, Davidson D, Sanderson RS, Allison DB, et al
Understanding these cardiovascular effects helps clinicians and patients make informed decisions when managing coexisting metabolic and cardiovascular conditions
Allergic reaction: Dry lips can be a sign of an allergic reaction
One mother did say she noticed some gastrointestinal side effects (which are common with semaglutide) in her child